BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 28439676)

  • 1. Post-recurrence chemotherapy for mesothelioma patients undergoing extrapleural pneumonectomy.
    Takuwa T; Hashimoto M; Matsumoto S; Kondo N; Kuribayash K; Nakano T; Hasegawa S
    Int J Clin Oncol; 2017 Oct; 22(5):857-864. PubMed ID: 28439676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Pleurectomy/Decortication Superior to Extrapleural Pneumonectomy for Patients with Malignant Pleural Mesothelioma? A Single-Institutional Experience.
    Miyazaki T; Yamasaki N; Tsuchiya T; Matsumoto K; Kamohara R; Hatachi G; Nagayasu T
    Ann Thorac Cardiovasc Surg; 2018 Apr; 24(2):81-88. PubMed ID: 29367501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic Therapy Use and Outcomes After Relapse from Preoperative Radiation and Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma.
    Soldera SV; Kavanagh J; Pintilie M; Leighl NB; de Perrot M; Cho J; Hope A; Feld R; Bradbury PA
    Oncologist; 2019 Jul; 24(7):e510-e517. PubMed ID: 30478189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): Feasibility and results.
    Rea F; Marulli G; Bortolotti L; Breda C; Favaretto AG; Loreggian L; Sartori F
    Lung Cancer; 2007 Jul; 57(1):89-95. PubMed ID: 17403553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological complete response in malignant pleural mesothelioma patients following induction chemotherapy: Predictive factors and outcomes.
    Lau B; Kumar S; Yan T; Burn J; Kennedy C; McLean J; Boyer M; McCaughan B; Kao S
    Lung Cancer; 2017 Sep; 111():75-78. PubMed ID: 28838403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does surgery improve survival of patients with malignant pleural mesothelioma?: a multicenter retrospective analysis of 1365 consecutive patients.
    Bovolato P; Casadio C; Billè A; Ardissone F; Santambrogio L; Ratto GB; Garofalo G; Bedini AV; Garassino M; Porcu L; Torri V; Pastorino U
    J Thorac Oncol; 2014 Mar; 9(3):390-6. PubMed ID: 24518090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial).
    Hasegawa S; Okada M; Tanaka F; Yamanaka T; Soejima T; Kamikonya N; Tsujimura T; Fukuoka K; Yokoi K; Nakano T
    Int J Clin Oncol; 2016 Jun; 21(3):523-30. PubMed ID: 26577445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial.
    Flores RM; Krug LM; Rosenzweig KE; Venkatraman E; Vincent A; Heelan R; Akhurst T; Rusch VW
    J Thorac Oncol; 2006 May; 1(4):289-95. PubMed ID: 17409872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrapleural pneumonectomy in the treatment of epithelioid malignant pleural mesothelioma: novel prognostic implications of combined N1 and N2 nodal involvement based on experience in 529 patients.
    Sugarbaker DJ; Richards WG; Bueno R
    Ann Surg; 2014 Oct; 260(4):577-80; discussion 580-2. PubMed ID: 25203873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical Risk and Survival Associated With Less Invasive Surgery for Malignant Pleural Mesothelioma.
    Hasegawa S; Kondo N; Matsumoto S; Takuwa T; Hashimoto M; Kuroda A; Nakamichi T; Kamikonya N; Tsujimura T; Nakano T
    Semin Thorac Cardiovasc Surg; 2019; 31(2):301-309. PubMed ID: 30639549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
    Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
    Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimodality therapy for malignant pleural mesothelioma.
    Buduhan G; Menon S; Aye R; Louie B; Mehta V; Vallières E
    Ann Thorac Surg; 2009 Sep; 88(3):870-5; discussion 876. PubMed ID: 19699914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrapleural pneumonectomy for malignant mesothelioma: an Italian multicenter retrospective study.
    Spaggiari L; Marulli G; Bovolato P; Alloisio M; Pagan V; Oliaro A; Ratto GB; Facciolo F; Sacco R; Brambilla D; Maisonneuve P; Mucilli F; Alessandrini G; Leoncini G; Ruffini E; Fontana P; Infante M; Pariscenti GL; Casiraghi M; Rea F
    Ann Thorac Surg; 2014 Jun; 97(6):1859-65. PubMed ID: 24726598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined modality treatment for malignant pleural mesothelioma: a single-centre long-term survival analysis using extrapleural pneumonectomy.
    Frick AE; Nackaerts K; Moons J; Lievens Y; Verbeken E; Lambrecht M; Coolen J; Dooms C; Vansteenkiste J; De Leyn P; Nafteux P
    Eur J Cardiothorac Surg; 2019 May; 55(5):934-941. PubMed ID: 30535191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome for patients with malignant pleural mesothelioma referred for Trimodality therapy in Western Australia.
    Hasani A; Alvarez JM; Wyatt JM; Bydder S; Millward M; Byrne M; Musk AW; Nowak AK
    J Thorac Oncol; 2009 Aug; 4(8):1010-6. PubMed ID: 19546819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy for malignant pleural mesothelioma: experience of Guy's and St Thomas' hospitals.
    Bille A; Belcher E; Raubenheimer H; Landau D; Cane P; Spicer J; Lang-Lazdunski L
    Gen Thorac Cardiovasc Surg; 2012 May; 60(5):289-96. PubMed ID: 22453539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical pleurectomy and chemoradiation for malignant pleural mesothelioma: the outcome of incomplete resections.
    Bölükbas S; Eberlein M; Fisseler-Eckhoff A; Schirren J
    Lung Cancer; 2013 Aug; 81(2):241-6. PubMed ID: 23688589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for major complications after extrapleural pneumonectomy for malignant pleural mesothelioma.
    de Perrot M; McRae K; Anraku M; Karkouti K; Waddell TK; Pierre AF; Darling G; Keshavjee S; Johnston MR
    Ann Thorac Surg; 2008 Apr; 85(4):1206-10. PubMed ID: 18355497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: a harmful procedure.
    Rena O; Casadio C
    Lung Cancer; 2012 Jul; 77(1):151-5. PubMed ID: 22244608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How does the timing of chemotherapy affect outcome following radical surgery for malignant pleural mesothelioma?
    Sharkey AJ; O'Byrne KJ; Nakas A; Tenconi S; Fennell DA; Waller DA
    Lung Cancer; 2016 Oct; 100():5-13. PubMed ID: 27597274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.